Mutual Fund Review: RELIANCE PHARMA FUND

Investment Strategy:

The fund invests in pharma and healthcare stocks across market capitalisation but focuses mainly on the large cap and small cap stocks. In the past three years, large cap stocks on an average account for about 46% of the portfolio, midcap stocks account for about 19% of the portfolio, small cap stocks account for about 28% of the portfolio and cash holdings account for 6% of the portfolio.

Investments in Pharmaceuticals companies account for about 89% of the portfolio on an average.

Asset Size:

The fund's AUM is around Rs. 552 crore as at 31 March 2011.

Performance:

This fund is the best performing Pharma fund in India and also the best performing Pharma fund on our platform over a 5 year period (31 December 2005 to 31 December 2010). We have been recommending this fund for the past two years.

As of 31 December 2010, this fund has outperformed its benchmark, the BSE Health care Index across all periods except for the 6 months and 1 year periods. Over a 1 year period, this fund has given 31.9% while its benchmark has given 34.2% and has given annualized returns of 27.2% over a 5 year period in comparison to 16.7% of the benchmark over the same 5 year period.